Analyst Ratings for Unicycive Therapeutics (UNCY)
UNCY Rating Summary
UNCY Price Target Summary
- Highest: $9.00 (Piper Sandler)
- Lowest: $4.50 (H.C. Wainwright)
- Average: $6.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$6.50 (+570.1%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$6.50 (+570.1%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/4/2024 | Piper Sandler | Yasmeen Rahimi | New Coverage | Overweight (N/A) |
9.00 (N/A) |
1.38 (0.97) |
-29.71% | Details |
| 2/14/2024 | Noble Capital | Robert LeBoyer | New Coverage | Outperform (N/A) |
6.00 (N/A) |
1.05 (0.97) |
-7.62% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
